Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
jorge.huetecarrasco@immonc.ox.ac.uk

ORCID
https://orcid.org/0000-0001-5088-0534

Research groups

Leung Group- Cancer Vaccines

Jorge Huete-Carrasco

PhD

Postdoctoral Scientist

Recent publications

Adsorption of antigen to polymeric nanoparticles enhances cytotoxic T-cell responses and anti-tumor immunity by targeting conventional type 1 dendritic cells.

Huete-Carrasco J. et al, (2025), Immunology and cell biology, 103, 825 - 843

Intratumoral delivery of the chitin-derived C100 adjuvant promotes robust STING, IFNAR, and CD8+ T cell-dependent anti-tumor immunity.

Turley JL. et al, (2024), Cell reports. Medicine, 5

Rational design of polymer-based particulate vaccine adjuvants.

Huete-Carrasco J. et al, (2024), European journal of immunology, 54

Immunostimulatory nanoparticles go viral.

Huete-Carrasco J. and Lavelle EC., (2023), Nature materials, 22, 273 - 275

[Bladder cancer immunological background and biomarkers.]

Valés-Gómez M. et al, (2020), Archivos espanoles de urologia, 73, 895 - 905

More publications